Indian Journal of Nuclear Medicine
Home | About IJNM | Search | Current Issue | Past Issues | Instructions | Ahead of Print | Online submissionLogin 
Indian Journal of Nuclear Medicine
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 118 Print this page  Email this page Small font size Default font size Increase font size
This article has been cited by
1Matrix-Metalloprotease Resistant Mucin-16 (MUC16) Peptide Mutants Represent a Worse Lung Adenocarcinoma Outcome
Jay S. Patel,Blake M. Callahan,Boris I. Chobrutskiy,George Blanck
PROTEOMICS Clinical Applications.2019;13(4)1800155
[DOI]
  Feedback 

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal